Brief: Onxeo Announces Start Of DRIIV Phase 1 Clinical Study Of AsiDNA

Valerio Therapeutics SA

24/04/2018 17:00

April 24 (Reuters) - ONXEO SA  C4X.PA :
    * DRIIV: FIRST INTERIM RESULTS EXPECTED IN H2 OF 2018
    * ANNOUNCES START OF DRIIV, PHASE 1 CLINICAL STUDY OF ASIDNA
IN
ADVANCED SOLID TUMORS

Source text for Eikon:  ID:nBwbGd4Cja 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))